David ‘DC’ Van Alstyne
Chief Executive Officer
DC is the managing director of ScotBio. He moved to Scotland from San Francisco 15 years ago to collaborate with Glasgow University. He has over 20 years experience in venture capital, intellectual property, defence contracting and the design and international marketing of new technologies. He raised money for public companies in the 80’s on Wall Street and later moved to the private equity markets. He has authored five US patents and two International patents in areas including micro-evolution, biological agent decontamination and concrete vitrification.
Polly Van Alstyne, MBA
Chief Operating Officer
Polly joined ScotBio in October 2016 and brings over 17 years of senior level operational experience, with specialisation in strategic operations, scale up and globalisation. Previously, Polly was a Director of London based Brainstorm Mobile Solutions, a telecommunications software company with responsibility for the overall operations at Brainstorm and managing the professional services, technical support and service delivery aspects of the business. Polly received her BS in international politics from Georgetown University and her MBA from the University of Strathclyde. Polly has been advising Scottish Bioenergy since inception.
Dr. Rocky Kindt
Head of Production
ScotBio sponsored Rocky’s Edinburgh University PhD ‘Characterisation and optimisation of secondary microbial communities in industrial bioreactors producing high-value chemicals’. Whilst involved in Scottish Bioenergy business since 2014, Rocky officially joined the company as head of production in January 2016. He runs the lab at Roslin where he handles all the operations for production and downstream processing. He has been instrumental in streaming the operational processes and increasing production.technical support and service delivery aspects of the business.
Tom brings a disciplined civil engineering and project management background to the team and has been instrumental in overcoming engineering challenges. He has been involved in University IP for the past 13 years. Tom left Glasgow University in 1999 where he was a commercialisation manager to co-found a medical device company with DC. Tom has been involved with ScotBio since incorporation.
Dr. Adam W. Bell
As an entrepreneur and patent attorney, Dr. Bell is working as an advisor to ScotBio. He is the founder of Bell and Associates, a patent law firm in San Francisco. Adam Bell holds a doctorate (D.Phil.) in Biochemistry from the University of Oxford (1994). He received his law degree from The University of California, Hastings College of the Law in San Francisco (1997). He practiced patent law with the Oregon firm of Klarquist Sparkman et al., and subsequently served as patent counsel at Incyte Genomics, and Durect Corporation (a medical devices company). Dr. Bell has served as scientific advisor to two biotech equity funds and currently serves as an advisor to Davis Bioscience Group and Nutragenomics Inc. From 1999-2001 he served on the board and as corporate secretary for the USPTO’s Patent and Trademark Depository Library in California. He also teaches patent administration. Dr. Bell is admitted to practice law in California and is registered to practice before the United States Patent and Trademark Office.
Dr. Matthew Kaser
Dr. Kaser is a licensed patent agent and is working as an advisor to ScotBio. Matthew Kaser received his doctorate (D.Phil.) in Biochemistry from the University of Oxford in 1988. He also holds a B.Sc. (Zoology) and M.Sc. (Biochemistry) from the University of Wales. After post-doctoral positions at the University of California and the University of Texas, Dr. Kaser held a post-doctoral fellowship in Molecular Endocrinology at the REI Harbor-UCLA Medical Center. He later held a faculty position at the UCSF Department of Pediatrics, and then served as a scientist at Incyte Genomics. Dr. Kaser has been practicing as a patent agent since 1999, first at Incyte, and then as Associate Director of Intellectual Property at Mendel Biotechnology. He is registered to practice before the United States Patent and Trademark Office.
Prof. John Raven, FRS, FRSE
Senior Scientific Advisor
Professor Raven is the senior scientist for ScotBio. Prof. Raven is a highly respected scientist and a member of the Royal Society of London and the Royal Society of Edinburgh. He graduated with a PhD. from Cambridge University and has been a leading researcher in microbiology, with specific emphasis on algae, for almost 40 years. He is currently the Boyd-Baxter Professor of Biology at Dundee University and a member of staff at the Scottish Crop Research Institute. He co-authored ‘Aquatic Photosynthesis’.
Dr. Chelsea Brain
ScotBio sponsored Chelsea’s Engineering Doctorate at Newcastle University. Chelsea’s research led to key discoveries and she is the co-inventor of the underlying IP related to phycocyanin production. With a background in both biochemistry and chemical engineering and extensive business training, Chelsea is currently working as the Intellectual Property Officer at the University of Surrey. She remains a valued advisor to the ScotBio team.
Alexander ‘Moley’ Campbell
Moley has been involved with the design, project management and manufacturing of the company’s products since incorporation. He works as an art director for film and television and is in charge of 3-D component design and development. Moley designed ScotBio’s initial reactor array at Glenturret Distillery as well as all later reactor models in use for the production of phycocyanin and other biochemicals. He has a BA (Hons)from Glasgow School of Art.